In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Mereo Biopharma Group Plc ADR (NASDAQ: MREO) was $0.42 for the day, up 12.47% from the previous closing price of $0.37. In other words, the price has increased by $12.47 from its previous closing price. On the day, 44.99 million shares were traded. MREO stock price reached its highest trading level at $0.4182 during the session, while it also had its lowest trading level at $0.333.
Ratios:
Our analysis of MREO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.71 and its Current Ratio is at 8.71. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 27, 2025, JP Morgan started tracking the stock assigning a Overweight rating and target price of $7.
On December 06, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $7.Jefferies initiated its Buy rating on December 06, 2024, with a $7 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MREO now has a Market Capitalization of 66310180 and an Enterprise Value of 283249888. For the stock, the TTM Price-to-Sale (P/S) ratio is 129.99 while its Price-to-Book (P/B) ratio in mrq is 1.42. Its current Enterprise Value per Revenue stands at 566.5 whereas that against EBITDA is -6.29.
Stock Price History:
The Beta on a monthly basis for MREO is 0.31, which has changed by -0.88820374 over the last 52 weeks, in comparison to a change of 0.15196204 over the same period for the S&P500. Over the past 52 weeks, MREO has reached a high of $3.84, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -77.70%, while the 200-Day Moving Average is calculated to be -79.85%.
Shares Statistics:
MREO traded an average of 6.88M shares per day over the past three months and 38300430 shares per day over the past ten days. A total of 159.10M shares are outstanding, with a floating share count of 137.51M. Insiders hold about 13.57% of the company’s shares, while institutions hold 57.43% stake in the company. Shares short for MREO as of 1765756800 were 9785445 with a Short Ratio of 1.42, compared to 1763078400 on 9249501. Therefore, it implies a Short% of Shares Outstanding of 9785445 and a Short% of Float of 8.649999999999999.
Earnings Estimates
The stock of Mereo Biopharma Group Plc ADR (MREO) is currently in the spotlight, with 6.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $0.0, with high estimates of $0.03 and low estimates of -$0.01.
Analysts are recommending an EPS of between -$0.04 and -$0.05 for the fiscal current year, implying an average EPS of -$0.04. EPS for the following year is -$0.03, with 5.0 analysts recommending between $0.03 and -$0.04.
